Percutaneous technique for hallux valgus correction: is it necessary to fix ?

Not Applicable

• Conditions: Patients diagnosed with moderate or severe hallux valgus (bunion), with no improvement after six months of conservative treatment and who have agreed and signed the informed consent form; 56365

• Registration Number: RBR-2chrm72
• Lead Sponsor: Instituto Prevent Senior

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-05-31
• Study Completion: 2022-08-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients diagnosed with moderate or severe hallux valgus, with no improvement after six months of conservative treatment and who have agreed and signed the informed consent form.

Exclusion Criteria

Patients with neuropathy, skin lesions, previous degenerative injuries to the ankle or previous surgeries on the ankle or foot, less than 16 years old, sequelae of fractures of the tibial pylon, ankle and foot. In addition, patients with collagen disorders, rheumatoid arthritis, seronegative arthritis will be excluded.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome will be the clinical evaluation using the visual analogue pain scale between baseline and 12 months after the surgical procedure.

Secondary Outcome Measures

Name	Time	Method
The secondary outcome will be functional assessment using the AOFAS metatarsophalangeal scale between baseline and 12 months after the surgical procedure.